When, how, why and whom for there will be an "after" Covid-19?

被引:0
|
作者
Tognoni, Gianni [1 ]
机构
[1] Fdn IRCSS Ca Granda Osped Maggiore Policlin, Milan, Italy
关键词
Covid-19; clinical trials; outcomes;
D O I
10.1702/3454.34432
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
The announced, but unpredicted, radical and global experience of the Covid-19 pandemia has revealed the degree of ignorance, fragmentation, inadequacy of the national and international knowledge and strategies of intervention and, even more substantially, of coordination across all the critical areas of prevention and care. The importance of the nursing component of the organisation and of the technical and cultural aspects of health care delivery and accessibility has been underlined as a protagonist of the resistance and resilience during the worst period of the emergency, and should be specifically involved in this renewal, where a profound modification of the interactions, hierarchies, roles of various professions is required. A long term, widespread, flexible experimentation of country specific and international solutions must be envisaged and timely activated. The 'grammar' and the major concrete characteristics of the methodology which could be usefully adopted to guarantee the feasibility and effectiveness of this 'systemic' experimentation are proposed and exemplified.
引用
收藏
页码:147 / 153
页数:7
相关论文
共 50 条
  • [1] Noninvasive respiratory support for COVID-19 patients: when, for whom, and how?
    Zachary P. Sullivan
    Luca Zazzeron
    Lorenzo Berra
    Dean R. Hess
    Edward A. Bittner
    Marvin G. Chang
    Journal of Intensive Care, 10
  • [2] Noninvasive respiratory support for COVID-19 patients: when, for whom, and how?
    Sullivan, Zachary P.
    Zazzeron, Luca
    Berra, Lorenzo
    Hess, Dean R.
    Bittner, Edward A.
    Chang, Marvin G.
    JOURNAL OF INTENSIVE CARE, 2022, 10 (01)
  • [3] How and why are rheumatologists relevant to COVID-19?
    Felten, Renaud
    Chatelus, Emmanuel
    Arnaud, Laurent
    JOINT BONE SPINE, 2020, 87 (04) : 279 - 280
  • [4] Dexamethasone in Patients Hospitalized with COVID-19: Whether, When and to Whom
    Calzetta, Luigino
    Aiello, Marina
    Frizzelli, Annalisa
    Rogliani, Paola
    Chetta, Alfredo
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (08)
  • [5] Anticoagulation in COVID-19: why, what, and when
    Taema, Khaled M.
    EGYPTIAN JOURNAL OF CHEST DISEASES AND TUBERCULOSIS, 2021, 70 (05): : 12 - 15
  • [6] Why skyscrapers after Covid-19?
    Smith, Richard G.
    FUTURES, 2021, 134
  • [7] How, when, and for whom: decisions regarding remote neuropsychological assessment during the 2020 COVID-19 pandemic
    Bloch, Ayala
    Maril, Sari
    Kave, Gitit
    ISRAEL JOURNAL OF HEALTH POLICY RESEARCH, 2021, 10 (01)
  • [8] COVID-19 and Hypertension: The What, the Why, and the How
    Muhamad, Shah-Abas
    Ugusman, Azizah
    Kumar, Jaya
    Skiba, Dominik
    Hamid, Adila A.
    Aminuddin, Amilia
    FRONTIERS IN PHYSIOLOGY, 2021, 12
  • [9] Bronchoscopy in COVID-19 patients: When, how and why. Experience in clinical practice
    Guarino, Carmine
    Cesaro, Cristiano
    Fiorentino, Giuseppe
    Rossi, Francesco
    Polverino, Benedetto Maria
    Fragranza, Fiorentino
    Monastra, Luca
    Murino, Patrizia
    Zamparelli, Enzo
    La Cerra, Giuseppe
    MONALDI ARCHIVES FOR CHEST DISEASE, 2021, 91 (02)
  • [10] How, when, and for whom: decisions regarding remote neuropsychological assessment during the 2020 COVID-19 pandemic
    Ayala Bloch
    Sari Maril
    Gitit Kavé
    Israel Journal of Health Policy Research, 10